Felix Berlth1, Stefan P Mönig2, Hans A Schlösser2, Martin Maus2, Christoph T H Baltin2, Alexander Urbanski2, Uta Drebber3, Elfriede Bollschweiler2, Arnulf H Hölscher2, Hakan Alakus4. 1. Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany felix.berlth@uk-koeln.de. 2. Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany. 3. Department of Pathology, University of Cologne, Cologne, Germany. 4. Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany Department of Pathology, University of Cologne, Cologne, Germany Division of Genome information Sciences, Department of Pediatrics and Rady Children's Hospital, University of California San Diego, La Jolla, CA, U.S.A.
Abstract
BACKGROUND/AIM: Tissue Microarray (TMA) is a widely used method to perform high-throughput immunohistochemical analyses on different tissues by arraying small sample cores from paraffin-fixed tissues into a single paraffin block. TMA-technology has been validated on numerous cancer tissues and also for gastric cancer studies, although it has not been validated for this tumor tissue so far. The objective of this study was to assess, whether the 2-mm TMA-technology is able to provide representative samples of gastric cancer tissue. MATERIALS AND METHODS: TMA paraffin blocks were constructed by means of 220 formalin-fixed and paraffin-embedded gastric cancer samples with a sample diameter of 2 mm. The agreement of immunohistochemical stainings of Glut-1 and Hif-1 alpha in TMA sections and the original full sections was calculated using kappa statistics and direct adjustment. RESULTS: The congruence was substantial for Glut-1 (kappa 0.64) and Hif-1 alpha (kappa 0.70), but with an agreement of only 71% and 52% within the marker-positive cases of the full-section slides. CONCLUSION: Due to tumor heterogeneity primarily, the TMA technology with a 2-mm sample core shows relevant limitations in gastric cancer tissue. Although being helpful for tissue screening purposes, the 2-mm TMA technology cannot be recommended as a method equal to full-section investigations in gastric cancer. Copyright
BACKGROUND/AIM: Tissue Microarray (TMA) is a widely used method to perform high-throughput immunohistochemical analyses on different tissues by arraying small sample cores from paraffin-fixed tissues into a single paraffin block. TMA-technology has been validated on numerous cancer tissues and also for gastric cancer studies, although it has not been validated for this tumor tissue so far. The objective of this study was to assess, whether the 2-mm TMA-technology is able to provide representative samples of gastric cancer tissue. MATERIALS AND METHODS:TMA paraffin blocks were constructed by means of 220 formalin-fixed and paraffin-embedded gastric cancer samples with a sample diameter of 2 mm. The agreement of immunohistochemical stainings of Glut-1 and Hif-1 alpha in TMA sections and the original full sections was calculated using kappa statistics and direct adjustment. RESULTS: The congruence was substantial for Glut-1 (kappa 0.64) and Hif-1 alpha (kappa 0.70), but with an agreement of only 71% and 52% within the marker-positive cases of the full-section slides. CONCLUSION: Due to tumor heterogeneity primarily, the TMA technology with a 2-mm sample core shows relevant limitations in gastric cancer tissue. Although being helpful for tissue screening purposes, the 2-mm TMA technology cannot be recommended as a method equal to full-section investigations in gastric cancer. Copyright
Authors: Floor J Backes; Christopher J Walker; Paul J Goodfellow; Erinn M Hade; Garima Agarwal; David Mutch; David E Cohn; Adrian A Suarez Journal: Gynecol Oncol Date: 2016-03-10 Impact factor: 5.482
Authors: K Trumpi; B L Emmink; A M Prins; M G H van Oijen; P J van Diest; C J A Punt; M Koopman; O Kranenburg; I H M Borel Rinkes Journal: J Cancer Date: 2015-09-03 Impact factor: 4.207